M

MoonLake Immunotherapeutics
NASDAQ:MLTX

Watchlist Manager
MoonLake Immunotherapeutics
NASDAQ:MLTX
Watchlist
Price: 51.06 USD -1.6% Market Closed
Market Cap: 3.3B USD
Have any thoughts about
MoonLake Immunotherapeutics?
Write Note

MoonLake Immunotherapeutics
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

MoonLake Immunotherapeutics
Operating Expenses Peer Comparison

Comparables:
ADCT
ACIU
CRSP
MOLN
XLS

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
M
MoonLake Immunotherapeutics
NASDAQ:MLTX
Operating Expenses
-$54.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
ADC Therapeutics SA
NYSE:ADCT
Operating Expenses
-$233m
CAGR 3-Years
-2%
CAGR 5-Years
-13%
CAGR 10-Years
N/A
AC Immune SA
NASDAQ:ACIU
Operating Expenses
-CHf75.5m
CAGR 3-Years
0%
CAGR 5-Years
-4%
CAGR 10-Years
N/A
CRISPR Therapeutics AG
NASDAQ:CRSP
Operating Expenses
-$535.2m
CAGR 3-Years
-3%
CAGR 5-Years
-19%
CAGR 10-Years
N/A
Molecular Partners AG
SIX:MOLN
Operating Expenses
-CHf85.9m
CAGR 3-Years
-4%
CAGR 5-Years
-11%
CAGR 10-Years
N/A
Xlife Sciences AG
SIX:XLS
Operating Expenses
-CHf20.7m
CAGR 3-Years
-89%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is MoonLake Immunotherapeutics's Operating Expenses?
Operating Expenses
-54.1m USD

Based on the financial report for Dec 31, 2023, MoonLake Immunotherapeutics's Operating Expenses amounts to -54.1m USD.

What is MoonLake Immunotherapeutics's Operating Expenses growth rate?
Operating Expenses CAGR 1Y
17%

Over the last year, the Operating Expenses growth was 17%.

Back to Top